Investigation of Gentamicin Release from Polydopamine Nanoparticles

Polydopamine (PDA), being highly reactive in nature, has acquired great attention in multi-disciplinary fields. Owing to its fascinating properties, including its biocompatible, non-toxic and readily bio-degradative nature, we investigated the drug loading and release behavior, using an aminoglycosi...

Full description

Bibliographic Details
Main Authors: Rahila Batul, Abdul Khaliq, Ahmed Alafnan, Mrinal Bhave, Aimin Yu
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/13/6319
_version_ 1797481118205739008
author Rahila Batul
Abdul Khaliq
Ahmed Alafnan
Mrinal Bhave
Aimin Yu
author_facet Rahila Batul
Abdul Khaliq
Ahmed Alafnan
Mrinal Bhave
Aimin Yu
author_sort Rahila Batul
collection DOAJ
description Polydopamine (PDA), being highly reactive in nature, has acquired great attention in multi-disciplinary fields. Owing to its fascinating properties, including its biocompatible, non-toxic and readily bio-degradative nature, we investigated the drug loading and release behavior, using an aminoglycoside antibiotic gentamicin (G) as a model drug. The gentamicin was loaded into the PDA nanoparticles (NPs) via an in situ polymerization method. The release kinetics of the gentamicin was then studied in pH 3, 5 and 7.4. Two batches with varied gentamicin loadings, G-PDA NPs 1:1 (with approx. 84.1% loaded gentamicin) and G-PDA NPs 0.6:1 (with approx. 72.7% loaded gentamicin), were studied. The drug release data were analyzed by LC–MS. The PDA showed good stability in terms of gentamicin release at alkaline pH over a period of seven days. The negative surface charge of PDA at pH 7.4 makes a strong bond with gentamicin, hence preventing its release from the PDA NPs. However, at pH 5 and 3, the amine groups of PDA are more prone towards protonation, making PDA positively charged, hence the repulsive forces caused the gentamicin to detach and release from the G-PDA NPs. Consequently, approx. 40% and 55% drug release were observed at pH 5 and 3, respectively, from the G-PDA NPs 1:1. However, the drug released from G-PDA NPs 0.6:1 was found to be one half as compared to the G-PDA NPs 1:1, which is obvious to the concentration gradient. These findings suggested that the in situ loading method for gentamicin could provide drug release over a period of seven days, hence defending the drug’s efficacy and safety challenges. Furthermore, two kinetic models, namely the Ritger–Peppas and Higuchi models, were implemented to determine the drug release kinetics. Curve fitting analysis supported our findings for the drug release kinetics which are followed by PDA structural changes in response to pH.
first_indexed 2024-03-09T22:09:55Z
format Article
id doaj.art-f0a3add023f44e6ab0317ec8645372e6
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-09T22:09:55Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-f0a3add023f44e6ab0317ec8645372e62023-11-23T19:34:32ZengMDPI AGApplied Sciences2076-34172022-06-011213631910.3390/app12136319Investigation of Gentamicin Release from Polydopamine NanoparticlesRahila Batul0Abdul Khaliq1Ahmed Alafnan2Mrinal Bhave3Aimin Yu4Department of Chemistry and Biotechnology, Swinburne University of Technology, Hawthorn, VIC 3122, AustraliaDepartment of Mechanical Engineering, College of Engineering, University of Ha’il, Ha’il 55211, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Ha’il, Ha’il 55211, Saudi ArabiaDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Hawthorn, VIC 3122, AustraliaDepartment of Chemistry and Biotechnology, Swinburne University of Technology, Hawthorn, VIC 3122, AustraliaPolydopamine (PDA), being highly reactive in nature, has acquired great attention in multi-disciplinary fields. Owing to its fascinating properties, including its biocompatible, non-toxic and readily bio-degradative nature, we investigated the drug loading and release behavior, using an aminoglycoside antibiotic gentamicin (G) as a model drug. The gentamicin was loaded into the PDA nanoparticles (NPs) via an in situ polymerization method. The release kinetics of the gentamicin was then studied in pH 3, 5 and 7.4. Two batches with varied gentamicin loadings, G-PDA NPs 1:1 (with approx. 84.1% loaded gentamicin) and G-PDA NPs 0.6:1 (with approx. 72.7% loaded gentamicin), were studied. The drug release data were analyzed by LC–MS. The PDA showed good stability in terms of gentamicin release at alkaline pH over a period of seven days. The negative surface charge of PDA at pH 7.4 makes a strong bond with gentamicin, hence preventing its release from the PDA NPs. However, at pH 5 and 3, the amine groups of PDA are more prone towards protonation, making PDA positively charged, hence the repulsive forces caused the gentamicin to detach and release from the G-PDA NPs. Consequently, approx. 40% and 55% drug release were observed at pH 5 and 3, respectively, from the G-PDA NPs 1:1. However, the drug released from G-PDA NPs 0.6:1 was found to be one half as compared to the G-PDA NPs 1:1, which is obvious to the concentration gradient. These findings suggested that the in situ loading method for gentamicin could provide drug release over a period of seven days, hence defending the drug’s efficacy and safety challenges. Furthermore, two kinetic models, namely the Ritger–Peppas and Higuchi models, were implemented to determine the drug release kinetics. Curve fitting analysis supported our findings for the drug release kinetics which are followed by PDA structural changes in response to pH.https://www.mdpi.com/2076-3417/12/13/6319polydopaminedrug deliverygentamicindrug release kineticskinetic models
spellingShingle Rahila Batul
Abdul Khaliq
Ahmed Alafnan
Mrinal Bhave
Aimin Yu
Investigation of Gentamicin Release from Polydopamine Nanoparticles
Applied Sciences
polydopamine
drug delivery
gentamicin
drug release kinetics
kinetic models
title Investigation of Gentamicin Release from Polydopamine Nanoparticles
title_full Investigation of Gentamicin Release from Polydopamine Nanoparticles
title_fullStr Investigation of Gentamicin Release from Polydopamine Nanoparticles
title_full_unstemmed Investigation of Gentamicin Release from Polydopamine Nanoparticles
title_short Investigation of Gentamicin Release from Polydopamine Nanoparticles
title_sort investigation of gentamicin release from polydopamine nanoparticles
topic polydopamine
drug delivery
gentamicin
drug release kinetics
kinetic models
url https://www.mdpi.com/2076-3417/12/13/6319
work_keys_str_mv AT rahilabatul investigationofgentamicinreleasefrompolydopaminenanoparticles
AT abdulkhaliq investigationofgentamicinreleasefrompolydopaminenanoparticles
AT ahmedalafnan investigationofgentamicinreleasefrompolydopaminenanoparticles
AT mrinalbhave investigationofgentamicinreleasefrompolydopaminenanoparticles
AT aiminyu investigationofgentamicinreleasefrompolydopaminenanoparticles